On my homepage services are described related to the pharmaceutical machines manufactured for the aseptic production of drug product.
These processes must be validated according to the applicable pharmaceutical regulations. The qualification of equipment is offered often and in different ways by the equipment manufacturers as a service.
The validation of the processes is running in most cases under the direction of the pharmaceutical companies.
During the validation it is demonstrated that the process meets the requirements for preparation of a drug. This requires a good knowledge of the system functions as well as a detailed knowledge of the pharmaceutical regulations.
At this interface often interdisciplinary teams are working on the qualification / validation of the systems. The services presented on this pages provide the necessary professional knowledge and experience for the work at this interfaces. The experiences gained during this collaboration promote the understanding for the overall pharmaceutical process (PAT).
The innovative approach - PAT - demands a risk assessment and minimization for the manufacturing processes to ensure the quality of pharmaceutical products. For this, a detailed understanding of the relevant processes is necessary. Quality should arise already during the manufacturing process and not afterwards determined by test. - „The goal of PAT is to enhance understanding and control the manufacturing process, which is consistent with our current drug quality system: quality cannot be tested into products; it should be built-in or should be by design.” 1. (FDA, Guidance for Industry: PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, September 2004, S. 4)
Bibliography:
1. FDA, Guidance for Industry: PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
September 2004, http://www.fda.gov
Picture:
k8442331 / www.fotosearch.de